The management of women of childbearing age with rheumatoid arthritis: an expert report

References

• Aljary H, Czuzoj-Shulman N, Spence AR, et al. Pregnancy outcomes in women with rheumatoid arthritis: a retrospective population-based cohort study. J Matern Fetal Neonatal Med. 2020;33(4):618–624. DOI:10.1080/14767058.2018.1498835.
   PubMed Web of Science ®Google Scholar
• Smeele HT, Röder E, Wintjes HM, et al. Modern treatment approach results in low disease activity in 90% of pregnant rheumatoid arthritis patients: the PreCARA study. Ann Rheum Dis. 2021;80(7):859–864. DOI:10.1136/annrheumdis-2020-219547
   PubMed Web of Science ®Google Scholar
• Sammaritano LR, Bermas BL, Chakravarty EE, et al. American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Rheumatol. 2020;72(4):529–556. DOI:10.1002/art.41191. .
   PubMed Web of Science ®Google Scholar
• Briggs AM, Jordan JE, Ackerman IN, et al. Establishing cross-discipline consensus on contraception, pregnancy and breast feeding-related educational messages and clinical practices to support women with rheumatoid arthritis: an Australian Delphi study. BMJ Open. 2016;6(9):e012139. DOI:10.1136/bmjopen-2016-012139. .
   PubMed Web of Science ®Google Scholar
• Murray K, Moore L, O’brien C, et al. A multidisciplinary approach to reproductive healthcare in women with rheumatic disease. Ir J Med Sci. 2020;189(1):237–243. DOI:10.1007/s11845-019-02040-5
   PubMed Web of Science ®Google Scholar
• Østensen M, Andreoli L, Brucato A, et al. State of the art: reproduction and pregnancy in rheumatic diseases. Autoimmun Rev. 2015;14(5):376–386. DOI:10.1016/j.autrev.2014.12.011
   PubMed Web of Science ®Google Scholar
• Japan Council for Quality Health Care. Method of evaluationg, and listing published clinical practice guidelines. Available from: https://minds.jcqhc.or.jp/english/s/method_of_evaluationg_and_listing_published_clinical_practice_guidelines
   Google Scholar
• Morizane T, Okumura A, Sato Y, et al. Minds manual for clinical practice guideline development 2020 ver. 3.0. Japan Council for Quality Health Care; Tokyo: 2021. Available from: https://minds.jcqhc.or.jp/docs/various/manual_2020/ver3_0/pdf/all_manual_2020ver3_0.pdf
   Google Scholar
• Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490.
   PubMed Web of Science ®Google Scholar
• Al-Emadi S, Abutiban F, El Zorkany B, et al. Enhancing the care of women with rheumatic diseases during pregnancy: challenges and unmet needs in the Middle East. Clin Rheumatol. 2016;35(1):25–31. DOI:10.1007/s10067-015-3052-5
   PubMed Web of Science ®Google Scholar
• El Miedany Y, Palmer D. Rheumatology-led pregnancy clinic: enhancing the care of women with rheumatic diseases during pregnancy. Clin Rheumatol. 2020;39(12):3593–3601. . DOI:10.1007/s10067-020-05173-6
   PubMed Web of Science ®Google Scholar
• Chakravarty E, Clowse ME, Pushparajah DS, et al. Family planning and pregnancy issues for women with systemic inflammatory diseases: patient and physician perspectives. BMJ Open. 2014;4(2):e004081. DOI:10.1136/bmjopen-2013-004081
   PubMed Web of Science ®Google Scholar
• Tsuda S, Sameshima A, Sekine M, et al. Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: multi-center retrospective descriptive study. Mod Rheumatol. 2020;30(5):852–861. DOI:10.1080/14397595.2019.1661592
   PubMed Web of Science ®Google Scholar
• Birru Talabi M, Clowse MEB, Blalock SJ, et al. Perspectives of adult rheumatologists regarding family planning counseling and care: a qualitative study. Arthritis Care Res (Hoboken). 2020;72(3):452–458. DOI:10.1002/acr.23872
   PubMed Web of Science ®Google Scholar
• Wolgemuth T, Stransky OM, Chodoff A, et al. Exploring the preferences of women regarding sexual and reproductive health care in the context of rheumatology: a qualitative study. Arthritis Care Res (Hoboken). 2021;73(8):1194–1200. DOI:10.1002/acr.24249
   PubMed Web of Science ®Google Scholar
• Bortoluzzi A, Andreoli L, Carrara G, et al. Improved pregnancy outcome in patients with rheumatoid arthritis who followed an ideal clinical pathway. Arthritis Care Res (Hoboken). 2021;73(2):166–172. DOI:10.1002/acr.24116
   PubMed Web of Science ®Google Scholar
• Kishore S, Mittal V, Majithia V. Obstetric outcomes in women with rheumatoid arthritis: results from nationwide inpatient sample database 2003–2011✰. Semin Arthritis Rheum. 2019;49(2):236–240.
   PubMed Web of Science ®Google Scholar
• Simms KT, Hanley SJB, Smith MA, et al. Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study. Lancet Public Health. 2020;5(4):e223–34. DOI:10.1016/S2468-2667(20)30010-4
   PubMed Web of Science ®Google Scholar
• Yagi A, Ueda Y, Ikeda S, et al. The looming health hazard: a wave of HPV-related cancers in Japan is becoming a reality due to the continued suspension of the governmental recommendation of HPV vaccine. Lancet Reg Health West Pac. 2022;18:100327.
   PubMedGoogle Scholar
• Nakagawa S, Ueda Y, Yagi A, et al. Corrected human papillomavirus vaccination rates for each birth fiscal year in Japan. Cancer Sci. 2020;111(6):2156–2162. DOI:10.1111/cas.14406
   PubMed Web of Science ®Google Scholar
• Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191–203. DOI:10.1016/S2214-109X(19)30482-6
   PubMed Web of Science ®Google Scholar
• Bonjour M, Charvat H, Franco EL, et al. Global estimates of expected and preventable cervical cancers among girls born between 2005 and 2014: a birth cohort analysis. Lancet Public Health. 2021;6(7):e510–21. DOI:10.1016/S2468-2667(21)00046-3
   PubMed Web of Science ®Google Scholar
• Brisson M, Kim JJ, Canfell K, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395(10224):575–590. DOI:10.1016/S0140-6736(20)30068-4
   PubMed Web of Science ®Google Scholar
• Falcaro M, Castañon A, Ndlela B, et al. The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study. Lancet. 2021;398(10316):2084–2092. DOI:10.1016/S0140-6736(21)02178-4
   PubMed Web of Science ®Google Scholar
• Brouwer J, Hazes JM, Laven JS, et al. Fertility in women with rheumatoid arthritis: influence of disease activity and medication. Ann Rheum Dis. 2015;74(10):1836–1841. DOI:10.1136/annrheumdis-2014-205383
   PubMed Web of Science ®Google Scholar
• Ince-Askan H, Dolhain RJ. Pregnancy and rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2015;29(4–5):580–596.
   PubMed Web of Science ®Google Scholar
• de Man Ya, Hazes JMW, van der Heide H, et al. Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study. Arthritis Rheum. 2009;60(11):3196–3206. DOI:10.1002/art.24914
   PubMed Web of Science ®Google Scholar
• Saito S Treatment guidelines for pregnancy and childbirth in female patients with systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), and inflammatory bowel disease (IBD 2018. Available from: https://ra-ibd-sle-pregnancy.org/index.html
   Google Scholar
• Birru Talabi M, Clowse MEB. Antirheumatic medications in pregnancy and breastfeeding. Curr Opin Rheumatol. 2020;32(3):238–246.
   PubMed Web of Science ®Google Scholar
• Götestam Skorpen C, Hoeltzenbein M, Tincani A, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75(5):795–810. DOI:10.1136/annrheumdis-2015-208840. .
   PubMed Web of Science ®Google Scholar
• van den Brandt S, Zbinden A, Baeten D, et al. Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients. Arthritis Res Ther. 2017;19(1):64. DOI:10.1186/s13075-017-1269-1
   PubMedGoogle Scholar
• Gerardi MC, Crisafulli F, García-Fernandez A, et al. Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis. Front Pharmacol. 2022;13:887462.
   PubMed Web of Science ®Google Scholar
• Förger F, Bandoli G, Luo Y, et al. No association of discontinuing tumor necrosis factor inhibitors before gestational week twenty in well-controlled rheumatoid arthritis and juvenile idiopathic arthritis with a disease worsening in late pregnancy. Arthritis Rheumatol. 2019;71(6):901–907. DOI:10.1002/art.40821
   PubMed Web of Science ®Google Scholar
• Russell MD, Dey M, Flint J, et al. British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford). 2022;keac551. DOI:10.1093/rheumatology/keac551
   Web of Science ®Google Scholar
• Mariette X, Förger F, Abraham B, et al. Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study. Ann Rheum Dis. 2018;77(2):228–233. DOI:10.1136/annrheumdis-2017-212196
   PubMed Web of Science ®Google Scholar
• Clowse MEB, Scheuerle AE, Chambers C, et al. Pregnancy outcomes after exposure to certolizumab pegol: updated results from a pharmacovigilance safety database. Arthritis Rheumatol. 2018;70(9):1399–1407. DOI:10.1002/art.40508
   PubMed Web of Science ®Google Scholar
• Clowse M, Fischer-Betz R, Nelson-Piercy C, et al. Pharmacovigilance pregnancy data in a large population of patients with chronic inflammatory disease exposed to certolizumab pegol. Ther Adv Musculoskelet Dis. 2022;14:1759720X221087650.
   PubMed Web of Science ®Google Scholar
• Murashima A, Watanabe N, Ozawa N, et al. Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant’s serum. Ann Rheum Dis. 2009;68(11):1793–1794. DOI:10.1136/ard.2008.105924
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists Committee on Gynecologic Practice and Practice Committee. Female age-related fertility decline. Committee Opinion No. 589. Fertil Steril. 2014;101: 633–634. DOI:10.1016/j.fertnstert.2013.12.032.
   Google Scholar
• Katagiri Y, Jwa SC, Kuwahara A, et al. Assisted reproductive technology in Japan: a summary report for 2019 by the Ethics Committee of the Japan Society of Obstetrics and Gynecology. Reprod Med Biol. 2021;21(1):e12434. DOI:10.1002/rmb2.12434
   PubMed Web of Science ®Google Scholar
• Weber-Schoendorfer C, Chambers C, Wacker E, et al. Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study. Arthritis Rheumatol. 2014;66(5):1101–1110. DOI:10.1002/art.38368
   PubMed Web of Science ®Google Scholar
• World Health Organization. Infertility fact sheet. 2020 Available from: https://www.who.int/news-room/fact-sheets/detail/infertility
   Google Scholar
• Lopez-Corbeto M, Martínez-Mateu S, Pluma A, et al. The ovarian reserve as measured by the anti-Müllerian hormone is not diminished in patients with rheumatoid arthritis compared to the healthy population. Clin Exp Rheumatol. 2021;39(2):337–343. DOI:10.55563/clinexprheumatol/73txen
   PubMed Web of Science ®Google Scholar
• Dai X, Wang Y, Yang H, et al. AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF/ICSI cycles. Sci Rep. 2020;10(1):19750. DOI:10.1038/s41598-020-76543-y
   PubMed Web of Science ®Google Scholar
• Broer SL, Broekmans FJ, Laven JS, et al. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update. 2014;20(5):688–701. DOI:10.1093/humupd/dmu020
   PubMed Web of Science ®Google Scholar
• Dimitriadis E, Menkhorst E, Saito S, et al. Recurrent pregnancy loss. Nat Rev Dis Primers. 2020;6(1):98. DOI:10.1038/s41572-020-00228-z
   PubMed Web of Science ®Google Scholar
• Morita K, Ono Y, Takeshita T, et al. Risk factors and outcomes of recurrent pregnancy loss in Japan. J Obstet Gynaecol Res. 2019;45(10):1997–2006. DOI:10.1111/jog.14083
   PubMed Web of Science ®Google Scholar
• Sugiura-Ogasawara M, Suzuki S, Ozaki Y, et al. Frequency of recurrent spontaneous abortion and its influence on further marital relationship and illness: the Okazaki Cohort Study in Japan. J Obstet Gynaecol Res. 2013;39(1):126–131. DOI:10.1111/j.1447-0756.2012.01973.x
   PubMed Web of Science ®Google Scholar
• Lockshin MD. Assisted reproductive technologies for women with rheumatic AID. Best Pract Res Clin Obstet Gynaecol. 2020;64:85–96.
   PubMed Web of Science ®Google Scholar
• Nørgård BM, Wod M, Larsen MD, et al. The impact of medical therapies and factors related to treatment procedures in women with rheumatoid arthritis and inflammatory bowel disease receiving assisted reproduction: a nationwide cohort study. Fertil Steril. 2021;116(6):1492–1500. DOI:10.1016/j.fertnstert.2021.07.1198
   PubMed Web of Science ®Google Scholar
• Mahagna H, Caplan A, Watad A, et al. Rheumatoid arthritis and thyroid dysfunction: a cross-sectional study and a review of the literature. Best Pract Res Clin Rheumatol. 2018;32(5):683–691. DOI:10.1016/j.berh.2019.01.021
   PubMed Web of Science ®Google Scholar
• Waldenlind K, Saevarsdottir S, Bengtsson C, et al. Risk of thyroxine-treated autoimmune thyroid disease associated with disease onset in patients with rheumatoid arthritis. JAMA Netw Open. 2018;1(6):e183567. DOI:10.1001/jamanetworkopen.2018.3567
   PubMed Web of Science ®Google Scholar
• Pan XF, Gu JQ, Shan ZY. Increased risk of thyroid autoimmunity in rheumatoid arthritis: a systematic review and meta-analysis. Endocrine. 2015;50(1):79–86.
   PubMed Web of Science ®Google Scholar
• Smeele HTW, Schreurs MWJ, Costedoat-Chalumeau N, et al. Low prevalence of anti-SSA (anti-Ro) and anti-SSB (anti-La) autoantibodies in female patients with rheumatoid arthritis with a wish to conceive. RMD Open. 2021;7(2):e001727. DOI:10.1136/rmdopen-2021-001727
   PubMed Web of Science ®Google Scholar
• Costedoat-Chalumeau N, Morel N, Fischer-Betz R, et al. Routine repeated echocardiographic monitoring of fetuses exposed to maternal anti-SSA antibodies: time to question the dogma. Lancet Rheumatol. 2019;1(3):E187–E193. DOI:10.1016/S2665-9913(19)30069-4
   Google Scholar
• El Hasbani G, Viola M, Sciascia S, et al. Antiphospholipid antibodies in inflammatory and autoimmune rheumatic and musculoskeletal diseases beyond lupus: a systematic review of the available evidence. Rheumatol Ther. 2021;8(1):81–94. DOI:10.1007/s40744-020-00273-w
   PubMed Web of Science ®Google Scholar
• Carlin A, Alfirevic Z. Physiological changes of pregnancy and monitoring. Best Pract Res Clin Obstet Gynaecol. 2008;22(5):801–823.
   PubMed Web of Science ®Google Scholar
• Harris N, Eudy A, Clowse M. Patient-reported disease activity and adverse pregnancy outcomes in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Care Res (Hoboken). 2019;71(3):390–397.
   PubMed Web of Science ®Google Scholar
• Bharti B, Lee SJ, Lindsay SP, et al. Disease severity and pregnancy outcomes in women with rheumatoid arthritis: results from the organization of teratology information specialists autoimmune diseases in pregnancy project. J Rheumatol. 2015;42(8):1376–1382. DOI:10.3899/jrheum.140583
   PubMed Web of Science ®Google Scholar
• Kawahito Y, Morinobu A, Kaneko Y, et al. Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis—secondary publication. Mod Rheumatol. 2022;33(1):21–35. 10.1093/mr/roac017
   Web of Science ®Google Scholar
• Jethwa H, Lam S, Smith C, et al. Does rheumatoid arthritis really improve during pregnancy? A systematic review and metaanalysis. J Rheumatol. 2019;46(3):245–250. DOI:10.3899/jrheum.180226
   PubMed Web of Science ®Google Scholar
• Kawaguchi R, Matsumoto K, Ishikawa T, et al. Guideline for gynecological practice in Japan: Japan society of obstetrics and gynecology and Japan Association of Obstetricians and Gynecologists 2020 edition. J Obstet Gynaecol Res. 2021;47(1):5–25. DOI:10.1111/jog.14487
   PubMed Web of Science ®Google Scholar
• Japan Radiological Society. Diagnostic imaging guidelines 2021. KANEHARA; Tokyo: 2021. Available from: http://www.radiology.jp/member_info/guideline/20210930_guideline.html
   Google Scholar
• Soh MC, Nelson-Piercy C. Biomarkers for adverse pregnancy outcomes in rheumatic diseases. Rheum Dis Clin North Am. 2017;43(2):201–214.
   PubMed Web of Science ®Google Scholar
• Bian X, Biswas A, Huang X, et al. Short-term prediction of adverse outcomes using the sFlt-1 (soluble fms-like tyrosine kinase 1)/PlGF (placental growth factor) ratio in Asian women with suspected preeclampsia. Hypertension. 2019;74(1):164–172. DOI:10.1161/HYPERTENSIONAHA.119.12760
   PubMed Web of Science ®Google Scholar
• Li L, Lu N, Avina-Galindo AM, et al. The risk and trend of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a general population-based study. Rheumatology (Oxford). 2021;60(1):188–195. DOI:10.1093/rheumatology/keaa262
   PubMed Web of Science ®Google Scholar
• Stevens SM, Woller SC, Baumann Kreuziger L, et al. Executive summary: antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report. Chest. 2021;160(6):2247–2259. DOI:10.1016/j.chest.2021.07.056
   PubMed Web of Science ®Google Scholar
• Royal College of Obstetricians and Gynecologists. Reducing the risk of venous thromboembolism during pregnancy and the puerperium: green-top guidelines number 37a. 2015. Available from: https://www.rcog.org.uk/media/qejfhcaj/gtg-37a.pdf
   Google Scholar
• Giles I, Yee CS, Gordon C. Stratifying management of rheumatic disease for pregnancy and breastfeeding. Nat Rev Rheumatol. 2019;15(7):391–402.
   PubMed Web of Science ®Google Scholar
• Gold KJ, Leon I, Boggs ME, et al. Depression and posttraumatic stress symptoms after perinatal loss in a population-based sample. J Womens Health (Larchmt). 2016;25(3):263–269. DOI:10.1089/jwh.2015.5284
   PubMed Web of Science ®Google Scholar
• Boyle FM, Horey D, Middleton PF, et al. Clinical practice guidelines for perinatal bereavement care — an overview. Women Birth. 2020;33(2):107–110. DOI:10.1016/j.wombi.2019.01.008
   PubMed Web of Science ®Google Scholar
• Giles I, Allen R, Nelson-Piercy C, et al. Best practice management of women of child-bearing age with inflammatory rheumatic diseases. 2020 Available from: https://www.guidelines.co.uk/musculoskeletal-and-joints-/women-of-child-bearing-age-with-inflammatory-rheumatic-diseases-guideline/455501.article
   Google Scholar
• de Man Ya, Dolhain RJEM, van de Geijn Fe, et al. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum. 2008;59(9):1241–1248. DOI:10.1002/art.24003
   PubMed Web of Science ®Google Scholar
• Østensen M, Fuhrer L, Mathieu R, et al. A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments. Ann Rheum Dis. 2004;63(10):1212–1217. DOI:10.1136/ard.2003.016881
   PubMed Web of Science ®Google Scholar
• de Man Ya, Bakker-Jonges LE, Goorbergh CM, et al. Women with rheumatoid arthritis negative for anti-cyclic citrullinated peptide and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantibody-positive women autoantibody levels are not influenced by pregnancy. Ann Rheum Dis. 2010;69(2):420–423. DOI:10.1136/ard.2008.104331
   PubMed Web of Science ®Google Scholar
• Smeele HTW, de Man YA, Röder E, et al. Parenting problems postpartum can be detected early in pregnancy in patients with rheumatoid arthritis. RMD Open. 2020;6(2):e001276. DOI:10.1136/rmdopen-2020-001276
   PubMed Web of Science ®Google Scholar
• Johns DG, Rutherford LD, Leighton PC, et al. Secretion of methotrexate into human milk. Am J Obstet Gynecol. 1972;112(7):978–980. DOI:10.1016/0002-9378(72)90824-1
   PubMed Web of Science ®Google Scholar
• Thorne JC, Nadarajah T, Moretti M, et al. Methotrexate use in a breastfeeding patient with rheumatoid arthritis. J Rheumatol. 2014;41(11):2332. DOI:10.3899/jrheum.140263
   PubMed Web of Science ®Google Scholar
• Clowse ME. The use of anti-TNFα medications for rheumatologic disease in pregnancy. Int J Womens Health. 2010;2:199–209.
   PubMedGoogle Scholar
• Julsgaard M, Christensen LA, Gibson PR, et al. Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection. Gastroenterology. 2016;151(1):110–119. DOI:10.1053/j.gastro.2016.04.002
   PubMed Web of Science ®Google Scholar
• Japanese Society for Pediatric Infectious Diseases. Guidelines of vaccination for pediatric transplant recipients and immunocompromised. 2014 (supplemental edition). Available from: https://www.jspid.jp/wp-content/uploads/2021/10/zouki_tsuiho.pdf.
   Google Scholar
• Japanese Academy Of Pediatrics. Timing of initial rotavirus innoculation (2nd edition) 2019. Available from: https://www.jpeds.or.jp/uploads/files/rotavirus_vaccine.pdf
   Google Scholar
• Ikram N, Eudy A, Clowse MEB. Breastfeeding in women with rheumatic diseases. Lupus Sci Med. 2021;8(1):e000491.
   PubMed Web of Science ®Google Scholar
• Chen H, Wang J, Zhou W, et al. Breastfeeding and risk of rheumatoid arthritis: a systematic review and metaanalysis. J Rheumatol. 2015;42(9):1563–1569. DOI:10.3899/jrheum.150195
   PubMed Web of Science ®Google Scholar
• Mills BS, Dao KH, Tecson KM, et al. Perceptions of pregnancy and lactation from the pregnancy and lactation autoimmune network registry. J Rheumatol. 2020;47(1):149–154. DOI:10.3899/jrheum.181067
   PubMed Web of Science ®Google Scholar
• Clowse ME, Förger F, Hwang C, et al. Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study. Ann Rheum Dis. 2017;76(11):1890–1896. DOI:10.1136/annrheumdis-2017-211384
   PubMed Web of Science ®Google Scholar
• Saito J, Yakuwa N, Kaneko K, et al. Clinical application of the dried milk spot method for measuring tocilizumab concentrations in the breast milk of patients with rheumatoid arthritis. Int J Rheum Dis. 2019;22:1130–1137.
   PubMed Web of Science ®Google Scholar
• Saito J, Yakuwa N, Takai C, et al. Abatacept concentrations in maternal serum and breast milk during breastfeeding and an infant safety assessment: a case study. Rheumatology (Oxford). 2019;58(9):1692–1694. DOI:10.1093/rheumatology/kez135
   PubMed Web of Science ®Google Scholar
• Admiraal LAC, Rosman AN, Dolhain RJEM, et al. Facilitators and barriers of preconception care in women with inflammatory bowel disease and rheumatic diseases: an explorative survey study in a secondary and tertiary hospital. Bmc Pregnancy Childbirth. 2022;22(1):238. DOI:10.1186/s12884-022-04560-y
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Barrett C, Hirano Y, et al. Management of chronic rheumatic diseases in women 18–45 years of age in Asia Pacific: insights from patient and clinician surveys. Rheumatol Int. 2022;43(4):721–733. DOI:10.1007/s00296-022-05206-0
   PubMed Web of Science ®Google Scholar
• Hum RM, David T, Lau YJ, et al. Pregnancy outcomes of a joint obstetric and rheumatology clinic in a tertiary centre: a 2-year retrospective study of 98 pregnancies. Rheumatol Adv Pract. 2022;6(1):rkac026. DOI:10.1093/rap/rkac026
   PubMedGoogle Scholar